Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 6:04 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 529–552 of 121,350 matching trials from the live ClinicalTrials.gov search.

Filters: Completed Clear all

Conditions: Cancer of Head and Neck
Interventions: Erbitux, Paclitaxel & Carboplatin, Radiation; Drug · Radiation
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years and older
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2012
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Healthy Subjects
Interventions: SKI-606; Drug
Lead sponsor: Wyeth is now a wholly owned subsidiary of Pfizer; Industry
Eligibility: 18 Years to 50 Years · Male only
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: Tacoma, Washington

Conditions: Epilepsy, Tumor, Healthy
Interventions: High-density electroencephalogram (HD-EEG); Diagnostic Test
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 122 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Uveal Melanoma
Interventions: Not listed
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2021
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Influenza A
Interventions: Low dose of VIS410, High dose of VIS410, Placebo; Drug
Lead sponsor: Visterra, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 21
States / cities: Tucson, Arizona • Stanford, California • St. Petersburg, Florida + 18 more

Conditions: Nutrition Immunology
Interventions: Cranberry, Placebo; Dietary Supplement
Lead sponsor: Appalachian State University; Other
Eligibility: 40 Years to 80 Years
Enrollment: 84 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Kannapolis, North Carolina

Conditions: Nicotine Dependence
Interventions: Tobacco Cigarette, Electronic Cigarette; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 21 Years and older
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 2
States / cities: San Francisco, California

Conditions: Individuals With Serious Mental Illness Leaving Jails
Interventions: Peer navigation intervention; Behavioral
Lead sponsor: Michigan State University; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Flint, Michigan

Conditions: Social Psychology
Interventions: Intranasal vasopressin, Intranasal placebo; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 30 Years
Enrollment: 84 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Dilated Cardiomyopathies, Idiopathic, Heart Failure, Systolic, Ventricular Remodeling, Electrical Remodeling
Interventions: Ivabradine, Placebo; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2023
U.S. locations: 2
States / cities: Aurora, Colorado • Columbus, Ohio

Conditions: Brain Edema, Brain Tumor
Interventions: hCRF, placebo hCRF; Drug
Lead sponsor: Celtic Pharma Development Services; Industry
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 27
States / cities: Phoenix, Arizona • Fresno, California • Newport Beach, California + 22 more

Conditions: Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases, Respiratory Tract Infections, Influenza
Interventions: Quadrivalent VLP Vaccine, Placebo; Biological
Lead sponsor: Medicago; Industry
Eligibility: 18 Years to 64 Years
Enrollment: 10,160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 29
States / cities: Mobile, Alabama • Anaheim, California • Milford, Connecticut + 23 more

Conditions: Pediatrics, Physical and Rehabilitation Medicine, Physical Therapy Modalities
Interventions: Telemedicine, In-Person Pediatric Physiatrist, In-Person Non-Pediatric Physiatrist; Other
Lead sponsor: University of California, Davis; Other
Eligibility: Up to 21 Years
Enrollment: 350 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Healthy
Interventions: aspirin; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 95 Years
Enrollment: 4 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Obesity, Overactive Bladder, Incontinence
Interventions: Trospium Chloride, Extended Release (XR), placebo; Drug · Other
Lead sponsor: Allergan; Industry
Eligibility: 18 Years to 75 Years · Female only
Enrollment: 127 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: La Mesa, California

Conditions: Abnormality, Respiratory System, Autonomic Nervous System
Interventions: Not listed
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 55 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: East Orange, New Jersey

Conditions: Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia
Interventions: MCS-2; Drug
Lead sponsor: Health Ever Bio-Tech Co., Ltd.; Industry
Eligibility: 40 Years and older · Male only
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Drug Interaction Study
Interventions: Pacritinib, Clarithromycin, Pacritinib and Clarithromycin; Drug
Lead sponsor: CTI BioPharma; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014
U.S. locations: 1
States / cities: Daytona Beach, Florida

Conditions: Atrial Fibrillation
Interventions: Dispersion ablation + PVI, VX1, PVI; Procedure · Device
Lead sponsor: Volta Medical; Industry
Eligibility: 18 Years and older
Enrollment: 377 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 8
States / cities: Birmingham, Alabama • Jacksonville, Florida • St Louis, Missouri + 5 more

Conditions: Non-alcoholic Steatohepatitis
Interventions: Vonafexor, Placebo; Drug · Other
Lead sponsor: Enyo Pharma; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 24
States / cities: North Little Rock, Arkansas • Lakewood Rch, Florida • Ocoee, Florida + 19 more

Conditions: Pre-diabetes
Interventions: L-Arabinose and Chromium, Sucrose without dietary Supplement; Dietary Supplement
Lead sponsor: Integrative Health Technologies, Inc.; Network
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Cataract Extraction, Corneal Astigmatism
Interventions: Visual performance measures; Other
Lead sponsor: Alcon Research; Industry
Eligibility: 50 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2009
U.S. locations: 1
States / cities: Fort Worth, Texas

Conditions: Hip Injuries
Interventions: DePuy Synthes total hip arthroplasty, Computer tomography, Fluoroscopy surveillance; Device · Radiation
Lead sponsor: The University of Tennessee, Knoxville; Other
Eligibility: 40 Years to 85 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 3
States / cities: Cumming, Georgia • Knoxville, Tennessee

Conditions: Nonsuicidal Self-Injury, Anxiety
Interventions: Acceptance and Commitment Therapy (ACT); Behavioral
Lead sponsor: Southern Methodist University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Dallas, Texas

Search by objective public record fields.

Evaluation of Cetuximab (ERBITUX) and Concurrent Carboplatin, Paclitaxel & Radiotherapy in the Management of Patients With Advanced Locoregional Squamous Cell Carcinomas of the Head and Neck (GCC 0442)

Study Evaluating The Mass Balance And Metabolic Disposition Of SKI-606

High-density EEG in Neurological Disorders

Vascular Response to Brachytherapy Using Functional OCT

Study of Efficacy and Safety of IV VIS410 Plus Oseltamivir Versus Oseltamivir in Hospitalized Adults With Influenza A

Cranberry Supplementation, Viral Defense, Antibody Response to the Flu Shot

Clinical Pharmacology of Electronic Cigarettes

Peer Navigation for Individuals With Serious Mental Illness Leaving Jail

Vasopressin and the Social Brain

Pulse Reduction On Beta-blocker and Ivabradine Therapy

XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors

Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in Adults

School-Based Tele-Physiatry Assistance for Rehabilitative and Therapeutic Services

Effect of Daily Low Dose Aspirin on Exhaled Inflammatory Mediators in Normal Subjects

Trospium Chloride XR in Obese Female Patients With Overactive Bladder

Effects of Deployment Exposures on Cardiopulmonary and Autonomic Function

Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (MCS-2-US-c)

To Evaluate the Effect of Clarithromycin on the Systemic Exposure of Pacritinib in Healthy Subjects

Tailored vs. Anatomical Ablation Strategy for Persistent Atrial Fibrillation

Safety, Tolerability, Pharmacokinetics and Efficacy of EYP001a in Patients With Nonalcoholic Steatohepatitis (NASH)

Effects of a Dietary Supplement Containing L-Arabinose and Trivalent Patented Food-source of Chromium on Blood Glucose and Insulin

Assessment of Visual Performance in Patients With Low Levels of Astigmatism

THA Kinematics and Sound for Subjects for Normal, Diseased and Implanted Hips

Acceptance and Commitment Therapy for Nonsuicidal Self-injury